NABIHEAL’s Post

📣 RESCHEDULED 📣 Our first webinar of 2024, Leachables sensitisation assessment framework in collaboration with Extractables & Leachables Safety Information Exchange (ELSIE), will take place on the 15th February 2024! The #ELSIE consortium was established in 2007 and unites pharmaceutical, biotechnology, and medical device companies with a shared vision of becoming the leading industry voice and scientific resource on #extractables and #leachables (E&Ls). In this #webinar, three ELSIE consortium members will discuss the sensitisation assessment framework of E&Ls and explore different routes of administration, including dermal, respiratory and parenteral. Moreover, there will be analysis of ELSIE/Product Quality Research Institute (PQRI) databases and illustrative case studies demonstrating each route of administration. Featured presenters and ELSIE consortium members include: 💡Patricia Parris (Ellis), Global Risk Assessment Services Toxicologist at Pfizer 💡Geraldine Whelan, Regulatory Toxicologist at GSK 💡Martyn Chilton, Principal Scientist at Lhasa Limited Register to attend: https://ow.ly/iW0U50Qrm5B 👈 #Sensitisation #Collaboration #Pharmaceutical #MedicalDevices

In Ireland, the landscape of innovative medicine is undergoing an extraordinary transformation. With a focus on pioneering research and development, Irish pharmaceutical companies are leading the charge in numerous fields, including biotechnology, personalized medicine, and advanced therapies. #ireland #tech #pharma #pharmotechs

Prof. Jerry Heng of Imperial College, UK, will be presenting “Peptide Crystallisation”, at the 5th Pharma Crystallization Summit in Session 1 -  Crystallization of Complex Pharmaceutical Compounds. You can read the abstract and brief speaker bio at https://lnkd.in/gP664ZFt Please register now to secure your seat, https://lnkd.in/eubD65m3 We look forward to another exciting PCS with stimulating and fruitful sharing and discussions on the pressing topics in support of today’s new drug development. #PharmaCrystallizationSummit #DebottleneckingDrugDevelopment #ChallengingCrystallization #ParticleEngineering #ComputationTool

BioMarin taps Amgen, Roche vets in executive reshuffle https://lnkd.in/gp3JCBjp Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. BioMarin is recasting some of its executive team, announcing Wednesday the appointments of two pharmaceutical industry veterans to [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News

Dr. Noalle Fellah, PhD of Pfizer will present “Vepdegestrant: Development of a Scalable Crystallization Process of a PROTAC Molecule”, at the 5th Pharma Crystallization Summit (#PCS2024) in Session 1 -  Crystallization of Complex Pharmaceutical Compounds. You can read the speaker bio at https://lnkd.in/e76hPaqs Please register now to secure your seat, https://lnkd.in/eubD65m3 We look forward to another exciting PCS with stimulating and fruitful sharing and discussions on the pressing topics in support of today’s new drug development. #PharmaCrystallizationSummit #DebottleneckingDrugDevelopment #ChallengingCrystallization #ParticleEngineering #ComputationTool

Publishing in reputable journals adds credibility to your research. Kindly submit your research work at the GLOBAL RESEARCH JOURNAL OF PHARMACEUTICAL & DRUG DISCOVERY Submit your papers here: https://lnkd.in/gUY_w_Y #DrugDiscoverySummit #PathologyResearch #InnovativeDrugs #DiseasePathology #DrugDevelopment #MolecularPathology #PharmaResearch #ClinicalPathology #BioPharma #TranslationalResearch #DrugInnovation #PathologyConference

With up to 40% of drugs on the market exhibiting poor solubility or bioavailability, it is still one of the biggest hurdles in #DrugDevelopment. Veranova's VP and General Manager, Cambridge, Craig Grant, recently spoke to International Pharmaceutical Industry Journal to discuss innovative solutions and strategies that can be harnessed to advance poorly soluble drugs. Read the full interview now to learn more about the power of solid form and particle engineering during early development: https://lnkd.in/egUavXP5

👏👏Take another look at our #HighlyCitedPaper by Dafina Fondaj et al: "Exploring the Microfluidic Production of Biomimetic Hybrid Nanoparticles and Their Pharmaceutical Applications" Paper link: https://shorturl.at/rPaTc

We’re pleased to share our latest insights on the critical role of polymorphism in drug development. Authored by Giovanna Brancatelli, Principal Scientist – Scientific Director at Ardena Solid State Research, our comprehensive article, featured in the International Pharmaceutical Industry Journal Summer 2024 issue, delves into how polymorph screening can significantly impact the stability, efficacy, and quality of drug products. Discover why early-stage polymorph screens are essential, how they mitigate risks, and the innovative methods we employ to ensure robust drug development. Read the full article below. #Ardena #DrugDevelopment #SolidStateResearch #Polymorphism #Innovation #QualityControl

Find out how crystallographic data is crucial to accelerate drug development strategies and digital transformation in the pharmaceutical industry. 🔷Read our new blog from the webinar presented by Dr Robert Docherty, CCDC consultant for the Materials Science Team, and discover how structural science can help selecting the right molecule, the right design, and optimizing the manufacturing processes. 🔗https://lnkd.in/etcbk6mM #DrugDevelopment #Crystallography